POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Indonesia approves emergency use of Pfizer's COVID-19 vaccine

Christian Fernsby |
Indonesia's Food and Drug Authority (BPOM) has issued an emergency use authorization (EUA) for Pfizer's COVID-19 vaccine amid a spike in cases as the more contagious Delta variant has entered the country, an official said on Thursday.

Article continues below




"BPOM has issued the EUA for the vaccine produced by Pfizer and BioNTech with the mRNA platform," BPOM's head Penny K. Lukito told a virtual press conference.

Indonesia has an agreement to procure 50 million doses of Pfizer vaccine throughout 2021.

Indonesia has so far given EUA approvals to five COVID-19 vaccine producers, namely Sinovac, Sinopharm, Pfizer, Moderna and AstraZeneca.

Indonesia recorded on Thursday 56,757 new COVID-19 cases, the highest since the pandemic hit the country for the first time in March last year, bringing the total tally to 2,726,803.


What to read next

WHO validates Sinovac COVID-19 vaccine for emergency use
Delaying second Pfizer vaccines to 12 weeks significantly increases antibody responses in older people
New vaccine to provide 2-year protection